1377 Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development.
https://www.pnas.org/content/117/28/16587
1376 CRISPR–Cas12-based detection of SARS-CoV-2.
https://www.nature.com/articles/s41587-020-0513-4
1375 Microbiota modulate sympathetic neurons via a gut–brain circuit.
https://www.nature.com/articles/s41586-020-2474-7
1374 A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.
https://www.nature.com/articles/s41586-020-2286-9
1373 Proteomics of SARS-CoV-2-infected host cells reveals therapy targets.
https://www.nature.com/articles/s41586-020-2332-7
1372 Genome sequences from 112 patients with confirmed SARS-CoV-2 infection showed two clades of SARS-CoV-2 virus with similar virulence and clinical outcome, and clinical data from 326 cases suggest that T cell depletion and cytokine bursts are associated with a worse prognosis.
https://www.nature.com/articles/s41586-020-2355-0
1371 A neuromodulator produced by commensal Providencia bacteria that colonize the gut of Caenorhabditis elegans mimics the functions of the cognate host molecule to manipulate a sensory decision of the host.
https://www.nature.com/articles/s41586-020-2395-5
1370 Bacterial chemolithoautotrophy via manganese oxidation.
https://www.nature.com/articles/s41586-020-2468-5
1369 Oligodendrocytes that survive acute coronavirus infection induce prolonged inflammatory responses in the CNS.
https://www.pnas.org/content/117/27/15902
1368 Emergence of SARS-CoV-2 through recombination and strong purifying selection.
https://advances.sciencemag.org/content/6/27/eabb9153
|
